|
1
|
Baumgart DC and Carding SR: Inflammatory
bowel disease: Cause and immunobiology. Lancet. 369:1627–1640.
2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang GF, Ren JA, Liu S, Chen J, Gu GS,
Wang XB, Fan CG and Li JS: Clinical characteristics of non-perianal
fistulating Crohn's disease in China: A single-center experience of
184 cases. Chin Med J (Engl). 125:2405–2410. 2012.PubMed/NCBI
|
|
3
|
Su CG, Judge TA and Lichtenstein GR:
Extraintestinal manifestations of inflammatory bowel disease.
Gastroenterol Clin North Am. 31:307–327. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Williams H, Walker D and Orchard TR:
Extraintestinal manifestations of inflammatory bowel disease. Curr
Gastroenterol Rep. 10:597–605. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Veloso FT, Carvalho J and Magro F:
Immune-related systemic manifestations of inflammatory bowel
disease. A prospective study of 792 patients. J Clin Gastroenterol.
23:29–34. 1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Camus P, Piard F, Ashcroft T, Gal AA and
Colby TV: The lung in inflammatory bowel disease. Medicine
(Baltimore). 72:151–183. 1993.PubMed/NCBI
|
|
7
|
Hoffmann RM and Kruis W: Rare
extraintestinal manifestations of inflammatory bowel disease.
Inflamm Bowel Dis. 10:140–147. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Storch I, Sachar D and Katz S: Pulmonary
manifestations of inflammatory bowel disease. Inflamm Bowel Dis.
9:104–115. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ji XQ, Wang LX and Lu DG: Pulmonary
manifestations of inflammatory bowel disease. World J
Gastroenterol. 20:13501–13511. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Songür N, Songür Y, Tüzün M, Doğan I,
Tüzün D, Ensari A and Hekimoglu B: Pulmonary function tests and
high-resolution CT in the detection of pulmonary involvement in
inflammatory bowel disease. J Clin Gastroenterol. 37:292–298.
2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Higenbottam T, Cochrane GM, Clark TJ,
Turner D, Millis R and Seymour W: Bronchial disease in ulcerative
colitis. Thorax. 35:581–585. 1980.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Black H, Mendoza M and Murin S: Thoracic
manifestations of inflammatory bowel disease. Chest. 131:524–532.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marvisi M and Fornasari G: Is the lung a
target organ in inflammatory bowel disease? Recenti Prog Med.
92:774–777. 2001.PubMed/NCBI(In Italian).
|
|
14
|
Wang JY, Wang XY, Wu HY, Sun HY, Liu DM,
Zhang W, Jin CX and Wang SR: The association between pulmonary
function impairment and colon inflammation in ulcerative colitis
patients: A scientific basis for exterior-interior correlation
between lung and large intestine. Chin J Integr Med. 22:894–901.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ni L, Jing S, Zhu L, Yang X, Wang X and Tu
S: The immune change of the lung and bowel in an ulcerative colitis
rat model and the protective effect of sodium houttuyfonate
combined with matrine. Front Immunol. 13(888918)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yan X, Yu X, Jiang C, Cao Y, Zhu L, Du C
and Jia Y: Tonifying-Qi-and-detoxification decoction attenuated
injuries of colon and lung tissues in ulcerative colitis rat model
via regulating NF-κB and p38MAPK pathway. Ann Transl Med.
10(455)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gupta SJ, Gupta VL, Kothari HG, Samarth
AR, Gaikwad NR and Parmar SM: Assessment of occult pulmonary
involvement in ulcerative colitis. Inflamm Intest Dis. 5:144–150.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Neilly JB, Main AN, McSharry C, Murray J,
Russell RI and Moran F: Pulmonary abnormalities in Crohn's disease.
Respir Med. 83:487–491. 1989.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yilmaz A, Yilmaz Demirci N, Hoşgün D, Uner
E, Erdoğan Y, Gökçek A and Cağlar A: Pulmonary involvement in
inflammatory bowel disease. World J Gastroenterol. 16:4952–4957.
2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pasquis P, Colin R, Denis P, Baptiste P,
Galmiche JP and Hecketsweiler P: Transient pulmonary impairment
during attacks of Crohn's disease. Respiration. 41:56–59.
1981.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mohamed-Hussein AA, Mohamed NA and Ibrahim
ME: Changes in pulmonary function in patients with ulcerative
colitis. Respir Med. 101:977–982. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tunc B, Filik L, Bilgic F, Arda K and
Ulker A: Pulmonary function tests, high-resolution computed
tomography findings and inflammatory bowel disease. Acta
Gastroenterol Belg. 69:255–260. 2006.PubMed/NCBI
|
|
23
|
Koek GH, Verleden GM, Evenepoel P and
Rutgeerts P: Activity related increase of exhaled nitric oxide in
Crohn's disease and ulcerative colitis: A manifestation of systemic
involvement? Respir Med. 96:530–535. 2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Louis E, Louis R, Drion V, Bonnet V,
Lamproye A, Radermecker M and Belaiche J: Increased frequency of
bronchial hyperresponsiveness in patients with inflammatory bowel
disease. Allergy. 50:729–733. 1995.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Graham BL, Steenbruggen I, Miller MR,
Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA,
McCarthy K, McCormack MC, et al: Standardization of spirometry 2019
update. an official American thoracic society and european
respiratory society technical statement. Am J Respir Crit Care Med.
200:e70–e88. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Riley CM, Wenzel SE, Castro M, Erzurum SC,
Chung KF, Fitzpatrick AM, Gaston B, Israel E, Moore WC, Bleecker
ER, et al: Clinical implications of having reduced mid forced
expiratory flow rates (FEF25-75), independently of FEV1, in adult
patients with asthma. PLoS One. 10(e0145476)2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Goyal A, Ghoshal UC, Nath A, Jindal S and
Mohindra S: Pulmonary function in patients with ulcerative colitis
and its relationship with disease severity. JGH Open. 1:32–37.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Godet PG, Cowie R, Woodman RC and
Sutherland LR: Pulmonary function abnormalities in patients with
ulcerative colitis. Am J Gastroenterol. 92:1154–1156.
1997.PubMed/NCBI
|
|
29
|
Karadag F, Ozhan MH, Akçiçek E, Günel O,
Alper H and Veral A: Is it possible to detect ulcerative
colitis-related respiratory syndrome early? Respirology. 6:341–346.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dierkes-Globisch A and Mohr H: Pulmonary
function abnormalities in respiratory asymptomatic patients with
inflammatory bowel disease. Eur J Intern Med.
13(385)2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao Y, Wang J, Liu Z, Lin H, Shi Y and
Sun X: Pulmonary dysfunction in 114 patients with inflammatory
bowel disease. Medicine (Baltimore). 96(e6808)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Heatley RV, Thomas P, Prokipchuk EJ,
Gauldie J, Sieniewicz DJ and Bienenstock J: Pulmonary function
abnormalities in patients with inflammatory bowel disease. Q J Med.
51:241–250. 1982.PubMed/NCBI
|
|
33
|
Douglas JG, McDonald CF, Leslie MJ, Gillon
J, Crompton GK and McHardy GJ: Respiratory impairment in
inflammatory bowel disease: Does it vary with disease activity?
Respir Med. 83:389–394. 1989.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Herrlinger KR, Noftz MK, Dalhoff K, Ludwig
D, Stange EF and Fellermann K: Alterations in pulmonary function in
inflammatory bowel disease are frequent and persist during
remission. Am J Gastroenterol. 97:377–381. 2002.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sethy PK, Dutta U, Aggrawal AN, Das R,
Gulati M, Sinha SK and Singh K: Pulmonary and hematological
alterations in idiopathic ulcerative colitis. Indian J
Gastroenterol. 22:176–179. 2003.PubMed/NCBI
|
|
36
|
Ateş F, Karincaoğlu M, Hacievlıyagıl SS,
Yalniz M and Seçkın Y: Alterations in the pulmonary function tests
of inflammatory bowel diseases. Turk J Gastroenterol. 22:293–299.
2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ellrichmann M, Bethge J, Boesenkoetter J,
Conrad C, Noth R, Bahmer T, Nikolaus S, Aden K, Zeissig S and
Schreiber S: Subclinical pulmonary involvement in active IBD
responds to biologic therapy. J Crohns Colitis. 15:1339–1345.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tzanakis N, Bouros D, Samiou M, Panagou P,
Mouzas J, Manousos O and Siafakas N: Lung function in patients with
inflammatory bowel disease. Respir Med. 92:516–522. 1998.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Johnson NM, Mee AS, Jewell DP and Clarke
SW: Pulmonary function in inflammatory bowel disease. Digestion.
18:416–418. 1978.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wallaert B, Colombel JF, Tonnel AB,
Bonniere P, Cortot A, Paris JC and Voisin C: Evidence of lymphocyte
alveolitis in Crohn's disease. Chest. 87:363–367. 1985.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Enright Md P: Office-based DLCO tests help
pulmonologists to make important clinical decisions. Respir
Investig. 54:305–311. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
O'Donnell CR, Bankier AA, Stiebellehner L,
Reilly JJ, Brown R and Loring SH: Comparison of plethysmographic
and helium dilution lung volumes: Which is best for COPD? Chest.
137:1108–1115. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shin TR, Oh YM, Park JH, Lee KS, Oh S,
Kang DR, Sheen S, Seo JB, Yoo KH, Lee JH, et al: The prognostic
value of residual volume/total lung capacity in patients with
chronic obstructive pulmonary disease. J Korean Med Sci.
30:1459–1465. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hopkins E and Sharma S: Physiology,
functional residual capacity. In: StatPearls [Internet]. StatPearls
Publishing, Treasure Island, FL, 2020. https://www.ncbi.nlm.nih.gov/books/NBK500007. Updated
September 28, 2020.
|
|
45
|
Lee MK, Yoon HK, Kim SW, Kim TH, Park SJ
and Lee YM: Nonspecific bronchoprovocation test. Tuberc Respir Dis
(Seoul). 80:344–350. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Davis BE, Blais CM and Cockcroft DW:
Methacholine challenge testing: Comparative pharmacology. J Asthma
Allergy. 11:89–99. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bohadana AB, Rokach A, Wild P and Izbicki
G: Asthma-like symptoms induced by the methacholine challenge test:
Do they predict a negative-to-positive switch in the test
result?-case report. J Thorac Dis. 10:E716–E720. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ceyhan BB, Karakurt S, Cevik H and Sungur
M: Bronchial hyperreactivity and allergic status in inflammatory
bowel disease. Respiration. 70:60–66. 2003.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Bartholo RM, Zaltman C, Elia C, Cardoso
AP, Flores V, Lago P, Cassabian L, Dorileo FC and Lapa-e-Silva JR:
Bronchial hyperresponsiveness and analysis of induced sputum cells
in Crohn's disease. Braz J Med Biol Res. 38:197–203.
2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Taylor DR, Pijnenburg MW, Smith AD and De
Jongste JC: Exhaled nitric oxide measurements: Clinical application
and interpretation. Thorax. 61:817–827. 2006.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Quenon L, Hindryckx P, De Vos M, De Looze
D, Joos G, Brusselle G and Peeters H: Hand-held fractional exhaled
nitric oxide measurements as a non-invasive indicator of systemic
inflammation in Crohn's disease. J Crohns Colitis. 7:644–648.
2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ozyilmaz E, Yildirim B, Erbas G, Akten S,
Oguzulgen IK, Tunc B, Tuncer C and Turktas H: Value of fractional
exhaled nitric oxide (FE NO) for the diagnosis of pulmonary
involvement due to inflammatory bowel disease. Inflamm Bowel Dis.
16:670–676. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ikonomi E, Rothstein RD, Ehrlich AC and
Friedenberg FK: Measurement of fractional exhaled nitric oxide as a
marker of disease activity in inflammatory bowel disease. J
Gastroenterol Pancreatol Liver Disord.
3(10.15226/2374-815X/3/1/00146)2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Protopapas AA, Vradelis S, Karampitsakos
T, Steiropoulos P, Chatzimichael A and Paraskakis E: Elevated
levels of alveolar nitric oxide may indicate presence of small
airway inflammation in patients with inflammatory bowel disease.
Lung. 197:663–670. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
El Amrousy DM, Hassan S, El-Ashry H,
Yousef M and Sharshar R: Pulmonary function tests abnormalities in
children with inflammatory bowel disease: Is it common? J Pediatr
Gastroenterol Nutr. 67:346–350. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Munck A, Murciano D, Pariente R, Cezard JP
and Navarro J: Latent pulmonary function abnormalities in children
with Crohn's disease. Eur Respir J. 8:377–380. 1995.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Furlano RI, Basek P, Müller P, Bieli C,
Braegger CP, Barben J, Hammer J, Moeller A and Trachsel D:
Pulmonary function test abnormalities in pediatric inflammatory
bowel disease. Respiration. 90:279–286. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Welsh L, Haller W, King LE, Soto-Martinez
M, Oliver M, Catto-Smith A and Robinson PJ: Pulmonary function
abnormalities in children with active Crohn's disease. Am J Respir
Crit Care Med. 186:1060–1061. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Mansi A, Cucchiara S, Greco L, Sarnelli P,
Pisanti C, Franco MT and Santamaria F: Bronchial
hyperresponsiveness in children and adolescents with Crohn's
disease. Am J Respir Crit Care Med. 161:1051–1054. 2000.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gut G, Ben-Tov A, Lahad A, Soferman R,
Cohen S, Tauman R and Sivan Y: Pulmonary functions in children with
inflammatory bowel disease. Eur J Gastroenterol Hepatol.
28:708–713. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Christie PM and Hill GL: Effect of
intravenous nutrition on nutrition and function in acute attacks of
inflammatory bowel disease. Gastroenterology. 90:730–736.
1990.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Stetter M, Schmidl M and Krapf R:
Azathioprine hypersensitivity mimicking Goodpasture's syndrome. Am
J Kidney Dis. 23:874–877. 1994.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Hollander D, Vadheim CM, Brettholz E,
Petersen GM, Delahunty T and Rotter JI: Increased intestinal
permeability in patients with Crohn's disease and their relatives.
A possible etiologic factor. Ann Intern Med. 105:883–885.
1986.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Fireman Z, Osipov A, Kivity S, Kopelman Y,
Sternberg A, Lazarov E and Fireman E: The use of induced sputum in
the assessment of pulmonary involvement in Crohn's disease. Am J
Gastroenterol. 95:730–734. 2000.PubMed/NCBI View Article : Google Scholar
|
